Julia Gavrilyuk
VP & Head of ADC Technology Development,
Adcytherix
Julia Gavrilyuk, VP & Head of ADC Technology Development at Adcytherix SAS, is an oncology drug discovery and therapeutic development leader with more than 25 years of pharmaceutical R&D experience spanning small-molecule discovery, biologics, antibody-drug conjugates (ADCs), translational research, and end-to-end preclinical development. She leads ADC technology strategy and multidisciplinary scientific programs, with expertise across target assessment, hit-to-lead and lead optimization, candidate selection, IND-enabling activities, and portfolio prioritization.
Sessions


